ConductScience.org, home

Paper36926237

Current status and prospect of treatments for recurrent hepatocellular carcinoma.

Yang YQ and 7 others. World J Hepatol, 2023. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Current status and prospect of treatments for recurrent hepatocellular carcinoma. Papers, record 36926237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36926237

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Current status and prospect of treatments for recurrent hepatocellular carcinoma.
PubMed
Journal
World J Hepatol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
2.26
iCite
Revised in PubMed
2023-03-18
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang YQYu-Qing
2Wen ZYZhen-Yu
3Liu XYXiao-Yan
4Ma ZHZhen-Hu
5Liu YEYan-E
6Cao XYXue-Ying
7Hou LLi
8Xie HHui

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References185

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135372050
Immune Checkpoint Inhibitor-Based Systemic Therapy Shows Remarkable Curative Effect in a Hepatocellular Carcinoma Patient With Intractable Postoperative Recurrence and Metastases: A Case Report and Literature Review.
Front Oncol2022https://conductscience.org/library/papers/35372050PubMed
235287627Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma.BMC Cancer2022https://conductscience.org/library/papers/35287627PubMed
331500650From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.J Exp Clin Cancer Res2019https://conductscience.org/library/papers/31500650PubMed
418650514Sorafenib in advanced hepatocellular carcinoma.N Engl J Med2008https://conductscience.org/library/papers/18650514PubMed
527598831Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials.Scand J Gastroenterol2016https://conductscience.org/library/papers/27598831PubMed
626981887Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.Oncotarget2016https://conductscience.org/library/papers/26981887PubMed
732108433Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation.Cancer Med2020https://conductscience.org/library/papers/32108433PubMed
828728985Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment.Int J Surg2017https://conductscience.org/library/papers/28728985PubMed
935693455Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant.Hepatoma Res2022https://conductscience.org/library/papers/35693455PubMed
1023393371Postoperative peak serum C-reactive protein predicts outcome of hepatic resection for hepatocellular carcinoma.Anticancer Res2013https://conductscience.org/library/papers/23393371PubMed
1122507499Re-resection for metachronous primary hepatocellular carcinoma: is it justified?ANZ J Surg2012https://conductscience.org/library/papers/22507499PubMed
1232940044Long-term clinical benefit of Peg-IFNα and NAs sequential anti-viral therapy on HBV related HCC.Neoplasma2021https://conductscience.org/library/papers/32940044PubMed
1319095782Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.Radiology2009https://conductscience.org/library/papers/19095782PubMed
1431058698Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.Ann Surg2021https://conductscience.org/library/papers/31058698PubMed
1531774468Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.JAMA Oncol2020https://conductscience.org/library/papers/31774468PubMed
1635360522R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation.JHEP Rep2022https://conductscience.org/library/papers/35360522PubMed
1723980077Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia.J Clin Oncol2013https://conductscience.org/library/papers/23980077PubMed
1822157201Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.Radiology2012https://conductscience.org/library/papers/22157201PubMed
1931730015Diffusion-weighted imaging for identifying patients at high risk of tumor recurrence following liver transplantation.Cancer Imaging2019https://conductscience.org/library/papers/31730015PubMed
2017006925Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.Hepatology2006https://conductscience.org/library/papers/17006925PubMed

See all 185 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42756218Sodium alginate-based dual-responsive nanoparticles co-loaded with baicalin and doxorubicin induce ferroptosis in hepatocellular carcinoma associated with the PI3K/AKT/FoxO3α axis regulation.Front Cell Dev Biol2026https://conductscience.org/library/papers/42756218PubMed
42169912Advances in mitophagy research in hepatocellular carcinoma: mechanisms and therapeutic implications.J Gastrointest Oncol2026https://conductscience.org/library/papers/42169912PubMed
41937376Prognostic Value and Related Molecular Mechanisms of miR-5003-3p in Hepatocellular Carcinoma.Can J Gastroenterol Hepatol2026https://conductscience.org/library/papers/41937376PubMed
41723802Construction of a prognostic model based on protein post-translational modification genes for prediction of immune characteristics and therapeutic response in hepatocellular carcinoma.Discov Oncol2026https://conductscience.org/library/papers/41723802PubMed
40956482Construction of a prognostic model for hepatocellular carcinoma based on necrosis by sodium overload-related genes and identification of ANKRD13B as a new prognostic marker.Funct Integr Genomics2025https://conductscience.org/library/papers/40956482PubMed
40870868Recent Advances in Magnetic Resonance Imaging for the Diagnosis of Liver Cancer: A Comprehensive Review.Diagnostics (Basel)2025https://conductscience.org/library/papers/40870868PubMed
40790550Elucidating the role of AC026412.3 in hepatocellular carcinoma: a prognostic disulfidptosis-related LncRNAs model perspective.BMC Gastroenterol2025https://conductscience.org/library/papers/40790550PubMed
40244531Based on disulfidptosis, unveiling the prognostic and immunological signatures of Asian hepatocellular carcinoma and identifying the potential therapeutic target ZNF337-AS1.Discov Oncol2025https://conductscience.org/library/papers/40244531PubMed
40066093
Efficacy and prognostic impact of preoperative risk factors for salvage liver transplantation and repeat hepatectomy in patients with early-stage recurrent hepatocellular carcinoma: a propensity score-matched analysis.
Front Oncol2025https://conductscience.org/library/papers/40066093PubMed
40057688Radiofrequency ablation versus stereotactic body radiotherapy for recurrent hepatocellular carcinoma: a multicenter, propensity score matching analysis.BMC Cancer2025https://conductscience.org/library/papers/40057688PubMed
39713637
Systematic Analysis of Disulfidptosis-Related lncRNAs in Hepatocellular Carcinoma with Vascular Invasion Revealed That AC131009.1 Can Promote HCC Invasion and Metastasis through Epithelial-Mesenchymal Transition.
ACS Omega2024https://conductscience.org/library/papers/39713637PubMed
39498055Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights.Heliyon2024https://conductscience.org/library/papers/39498055PubMed
39453585Comparison of Prognostic Outcomes Between Repeat Liver Resection and Particle Therapy for Patients with Recurrent Hepatocellular Carcinoma.Ann Surg Oncol2025https://conductscience.org/library/papers/39453585PubMed
39354529Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery.Mol Cancer2024https://conductscience.org/library/papers/39354529PubMed
39210306Construction of a prognostic model for disulfidptosis-related long noncoding RNAs in R0 resected hepatocellular carcinoma and analysis of their impact on malignant behavior.BMC Cancer2024https://conductscience.org/library/papers/39210306PubMed
38893206Preoperative Bone Loss Predicts Decreased Survival Associated with Microvascular Invasion after Resection of Hepatocellular Carcinoma.Cancers (Basel)2024https://conductscience.org/library/papers/38893206PubMed
38494848The cell death-related genes machine learning model for precise therapy and clinical drug selection in hepatocellular carcinoma.J Cell Mol Med2024https://conductscience.org/library/papers/38494848PubMed
37941812Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma.J Hepatocell Carcinoma2023https://conductscience.org/library/papers/37941812PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36926237

GET https://conductscience.org/api/papers/v1/36926237/references?page=2